共 94 条
[1]
Arnout J., Huybrechts E., Vermylen J., Further studies on the heterogeneity of antiphospholipid antibodies, Postgrad. Med. J, 65, (1989)
[2]
Alarcon-Segovia D., Cabral A.R., Functional and immunochemical heterogeneity of antiphospholipd antibodies – a classification, J. Rheumatol, 19, pp. 1166-1168, (1992)
[3]
Matsuura E., Igarashi Y., Yasuda T., Triplett D.A., Koike T., Anticardiolipin antibodies recognise B,-glyco-protein I structure altered by interacting with an oxygen modified solid phase surface, J. Expt. Med, 179, pp. 457-462, (1994)
[4]
Mercolino T.J., Arnold L.W., Hawkins L.A., Haughton G., Normal mouse peritoneum contains a large population of Ly-1 <sup>+</sup> (CD5) B cells that recognise phosphatidylcholine. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes, J. Expt. Med, 168, pp. 687-698, (1988)
[5]
Kawaguchi S., Antiphospholipid antibodies reactive with bromelain-treated mouse erythrocytes in mice, rats and rabbits, Int. Arch. Allergy Appl. Immunol, 96, pp. 46-50, (1991)
[6]
Cheng H.M., Antiphospholipid antibodies are masked in normal human serum, Immunol. Today, 12, (1991)
[7]
Asherson R.A., Cervera R., The antiphospholipid syndrome – a syndrome in evolution, Ann. Rheum. Dis, 51, pp. 147-150, (1992)
[8]
Harris E.N., The second international anti-cardiolipin standardization workshop, Am. J. Clin. Pathol, 94, pp. 476-484, (1990)
[9]
Soloninka C.A., Laskin C.A., Wither J., Wong D., Bombardier C., Raboud J., Clinical utility and specificity of anticardiolipin antibodies, J. Rheumatol, 18, pp. 1849-1855, (1991)
[10]
Petri M., The clinical syndrome associated with antiphospholipid antibodies, J. Rheumatol, 19, pp. 505-507, (1992)